Market Research Logo

Pneumonia Diagnostics Market: North America Projected to be the Most Lucrative Regional Market During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Pneumonia Diagnostics Market: North America Projected to be the Most Lucrative Regional Market During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Global Report with Exhaustive Focus on Emerging and Developed Regions

Future Market Insights provides a forecast of the global pneumonia diagnostics market in terms of value from 2017 to 2027. The study is an in-depth illustration of the trends and dynamics witnessed across the seven regions viz. Western Europe, Eastern Europe, North America, APEJ, Japan, and Latin America that impact current and future prospects in the global pneumonia diagnostics market.

Well-laid Out, Logical, Cohesive Report Structure

The research report includes a comprehensive assessment of the global pneumonia diagnostics market and delivers insights into the different factors contributing to the popularity of pneumonia diagnostics equipment. The report offers an analysis of important drivers, restraints, opportunities, and trends that shape the pneumonia diagnostics market along with an evaluation of stakeholder strategies to achieve success in the pneumonia diagnostics market. The report begins with an overview of the pneumonia diagnostics market that caters to a global audience by mentioning revenue figures in US dollars. Furthermore, the section comprises an analysis of all relevant factors from the demand and supply side that influence the pneumonia diagnostics market with a segmental break-down across all the studied regions.

A critical section of the report highlights the pneumonia diagnostics market across the regions. The market outlook is for the decade from 2017 to 2027 and mentions the forecast within the aforementioned period, including the latest technological developments coupled with new products available in the pneumonia diagnostics market. Region and country-specific trends are focused on at great length in the report and an investigation of these drivers is par for the course. The report takes into account the present and future scenario of the pneumonia diagnostics market by considering 2016 as the base year with all the requisite data provided for the readers’ benefit. For an accurate forecast, the current market is sized up to form the basis of predicting the future potential in the pneumonia diagnostics market.

The concluding section of the report consists of a competition dashboard that provides a holistic view of the pneumonia diagnostics market. The dashboard is in an easy-to-understand format and has a company overview, product portfolio, financials, strategies adopted, and recent developments in the pneumonia diagnostics market. This section makes it possible to make a detailed and objective assessment of key stakeholders in specific market segments of the pneumonia diagnostics market. Competitors can be identified based on their capabilities and success in the pneumonia diagnostics market and profiles go a long way in determining the strategies adopted by them to strengthen their competitive position in the pneumonia diagnostics market.

Fool-Proof, Robust Research Methodology

The research methodology devised by Future Market Insights is an industry leading one that is trusted by clients as an authoritative source on the pneumonia diagnostics market. Our team of experts have years of experience in the healthcare domain and begin their study with a winning combination of primary and secondary research to gain an initial understanding of the market. Forecasts are conducted not only in terms of CAGR but also with parameters such as Y-o-Y growth to gauge market predictability and tap the opportunities as they arise. The report undergoes several channels of validation and cross-verification to ensure accuracy to the highest standard and only trusted sources such as company releases, government websites, and industry journals are used to gather the necessary qualitative and quantitative insights.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Pneumonia Diagnostics Market View Point
3.1. Macro-Economic Factors
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Trends
3.3. Opportunity Analysis
3.4. Epidemiology of Pneumonia & Leading Causes of Pneumonia
4. North America Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
4.2.1. U.S.
4.2.2. Canada
4.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.3.1. U.S.
4.3.2. Canada
4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
4.4.1. Streptococcus based
4.4.2. Legionella based
4.4.3. Chlamydophila based
4.4.4. Mycoplasma Pneumonia based
4.4.5. Viral Pneumonia based
4.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
4.5.1. Streptococcus based
4.5.2. Legionella based
4.5.3. Chlamydophila based
4.5.4. Mycoplasma Pneumonia based
4.5.5. Viral Pneumonia based
4.6. Drivers and Restraints: Impact Analysis
4.7. Market Attractiveness Analysis
4.7.1. By Country
4.7.2. By Product Type
4.8. Key Representative Market Participants
4.9. Key Participants Market Presence (Intensity Map)
5. Western Europe Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012-2016
5.2.1. Germany
5.2.2. United Kingdom
5.2.3. France
5.2.4. Italy
5.2.5. Spain
5.2.6. Nordics
5.2.7. Rest of Western Europe
5.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017-2027
5.3.1. Germany
5.3.2. United Kingdom
5.3.3. France
5.3.4. Italy
5.3.5. Spain
5.3.6. Nordics
5.3.7. Rest of Western Europe
5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
5.4.1. Streptococcus based
5.4.2. Legionella based
5.4.3. Chlamydophila based
5.4.4. Mycoplasma Pneumonia based
5.4.5. Viral Pneumonia based
5.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
5.5.1. Streptococcus based
5.5.2. Legionella based
5.5.3. Chlamydophila based
5.5.4. Mycoplasma Pneumonia based
5.5.5. Viral Pneumonia based
5.6. Drivers and Restraints: Impact Analysis
5.7. Market Attractiveness Analysis
5.7.1. By Country
5.7.2. By Product Type
5.8. Key Representative Market Participants
5.9. Key Participants Market Presence (Intensity Map)
6. Eastern Europe Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
6.2.1. Russia
6.2.2. Poland
6.2.3. Rest of Eastern Europe
6.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
6.3.1. Russia
6.3.2. Poland
6.3.3. Rest of Eastern Europe
6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
6.4.1. Streptococcus based
6.4.2. Legionella based
6.4.3. Chlamydophila based
6.4.4. Mycoplasma Pneumonia based
6.4.5. Viral Pneumonia based
6.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
6.5.1. Streptococcus based
6.5.2. Legionella based
6.5.3. Chlamydophila based
6.5.4. Mycoplasma Pneumonia based
6.5.5. Viral Pneumonia based
6.6. Drivers and Restraints: Impact Analysis
6.7. Market Attractiveness Analysis
6.7.1. By Country
6.7.2. By Product Type
6.8. Key Representative Market Participants
6.9. Key Participants Market Presence (Intensity Map)
7. Latin America Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
7.3.1. Brazil
7.3.2. Mexico
7.3.3. Rest of Latin America
7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
7.4.1. Streptococcus based
7.4.2. Legionella based
7.4.3. Chlamydophila based
7.4.4. Mycoplasma Pneumonia based
7.4.5. Viral Pneumonia based
7.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
7.5.1. Streptococcus based
7.5.2. Legionella based
7.5.3. Chlamydophila based
7.5.4. Mycoplasma Pneumonia based
7.5.5. Viral Pneumonia based
7.6. Drivers and Restraints: Impact Analysis
7.7. Market Attractiveness Analysis
7.7.1. By Country
7.7.2. By Product Type
7.8. Key Representative Market Participants
7.9. Key Participants Market Presence (Intensity Map)
8. Japan Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
8.3.1. Streptococcus based
8.3.2. Legionella based
8.3.3. Chlamydophila based
8.3.4. Mycoplasma Pneumonia based
8.3.5. Viral Pneumonia based
8.4. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
8.4.1. Streptococcus based
8.4.2. Legionella based
8.4.3. Chlamydophila based
8.4.4. Mycoplasma Pneumonia based
8.4.5. Viral Pneumonia based
8.5. Drivers and Restraints: Impact Analysis
8.6. Market Attractiveness Analysis
8.6.1. By Product Type
8.7. Key Representative Market Participants
8.8. Key Participants Market Presence (Intensity Map)
9. Asia Pacific Excluding Japan Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
9.2.1. China
9.2.2. India
9.2.3. Australia and New Zealand
9.2.4. ASEAN
9.2.5. Rest of APEJ
9.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand
9.3.4. ASEAN
9.3.5. Rest of APEJ
9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
9.4.1. Streptococcus based
9.4.2. Legionella based
9.4.3. Chlamydophila based
9.4.4. Mycoplasma Pneumonia based
9.4.5. Viral Pneumonia based
9.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
9.5.1. Streptococcus based
9.5.2. Legionella based
9.5.3. Chlamydophila based
9.5.4. Mycoplasma Pneumonia based
9.5.5. Viral Pneumonia based
9.6. Drivers and Restraints: Impact Analysis
9.7. Market Attractiveness Analysis
9.7.1. By Country
9.7.2. By Product Type
9.8. Key Representative Market Participants
9.9. Key Participants Market Presence (Intensity Map)
10. Middle East and Africa Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of Middle East and Africa
10.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of Middle East and Africa
10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
10.4.1. Streptococcus based
10.4.2. Legionella based
10.4.3. Chlamydophila based
10.4.4. Mycoplasma Pneumonia based
10.4.5. Viral Pneumonia based
10.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
10.5.1. Streptococcus based
10.5.2. Legionella based
10.5.3. Chlamydophila based
10.5.4. Mycoplasma Pneumonia based
10.5.5. Viral Pneumonia based
10.6. Drivers and Restraints: Impact Analysis
10.7. Market Attractiveness Analysis
10.7.1. By Country
10.7.2. By Product Type
10.8. Key Representative Market Participants
10.9. Key Participants Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Market Share Analysis
13.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.2.1. Thermo Fisher Scientific Inc.
13.2.2. Alere Inc.
13.2.3. Quidel Corporation
13.2.4. Becton, Dickinson and Company
13.2.5. Meridian Bioscience, Inc.
13.2.6. Qiagen N.V.
13.2.7. bioMérieux SA
13.2.8. Bio-Rad Laboratories Inc.
13.2.9. Cardinal Health Inc.
13.2.10. Beckman Coulter Inc (Danaher Corporation)
14. Global Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027 By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Japan
14.2.6. Asia Pacific Excluding Japan
14.2.7. Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Japan
14.3.6. Asia Pacific Excluding Japan
14.3.7. Middle East and Africa
14.4. Market Attractiveness Analysis By Region
15. Global Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type
15.1. Introduction/Key Finding
15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
15.2.1. Streptococcus based
15.2.2. Legionella based
15.2.3. Chlamydophila based
15.2.4. Mycoplasma Pneumonia based
15.2.5. Viral Pneumonia based
15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
15.3.1. Streptococcus based
15.3.2. Legionella based
15.3.3. Chlamydophila based
15.3.4. Mycoplasma Pneumonia based
15.3.5. Viral Pneumonia based
15.4. Market Attractiveness Analysis By Product Type
16. Global Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
16.1. Market Size and Y-o-Y Growth
16.2. Absolute $ Opportunity
17. Assumptions and Acronyms Used
18. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report